CURI: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-2,641	1,103
Change in fair value of warrant liability	88	-86
Additions to content assets	-7,276	-4,179
Change in content liabilities	-196	120
Amortization of content assets	10,696	7,113
Depreciation and amortization expenses	122	83
Amortization of premiums and accretion of discounts associated with investments in debt securities, net	-454	-354
Stock-based compensation	10,054	3,077
Equity method investment loss	231	307
Other non-cash items	453	145
Accounts receivable	3,098	5,251
Other assets	-256	-335
Accounts payable	-2,788	-521
Accrued expenses and other liabilities	6,500	4,023
Deferred revenue	-2,683	-1,376
Net cash provided by operating activities	9,088	4,711
Purchases of property and equipment	77	77
Sales of investments in debt securities	3,500	2,000
Maturities of investments in debt securities	25,300	17,450
Purchases of investments in debt securities	11,807	11,070
Net cash provided by investing activities	16,916	8,303
Repurchases of common stock	0	0
Dividends paid	17,311	12,665
Payments related to tax withholding	2,476	1,297
Net cash used in financing activities	-19,787	-13,962
Net increase in cash, cash equivalents and restricted cash	6,217	-948
Cash and cash equivalents at beginning of period	7,951	-
Cash and cash equivalents at end of period	14,168	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

CURI: the cashflow